Hualan Biological Engineering
002007.SZ
#2983
Rank
A$6.37 B
Marketcap
$3.49
Share price
-0.67%
Change (1 day)
-13.49%
Change (1 year)
Hualan Biological Engineering Inc. is a Chinese pharmaceutical company that produces plasma products and vaccines.

Earnings for Hualan Biological Engineering (002007.SZ)

Earnings in 2024 (TTM): A$0.27 Billion

According to Hualan Biological Engineering's latest financial reports the company's current earnings are A$0.61 Billion. a decrease over its 2023 earnings that were of A$0.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Hualan Biological Engineering from 2004 to 2024

Annual earnings

Year Earnings Change
2024 A$0.29 B-35.98%
2023 A$0.45 B39.21%
2022 A$0.32 B-19.12%
2021 A$0.40 B-17.9%
2020 A$0.49 B37.11%
2019 A$0.36 B11.71%
2018 A$0.32 B50.84%
2017 A$0.21 B1.1%
2016 A$0.21 B23.49%
2015 A$0.17 B8.37%
2014 A$0.15 B10.83%
2013 A$0.14 B54.56%
2012 A$92.61 M-17.03%
2011 A$0.11 B-41.34%
2010 A$0.19 B6.15%
2009 A$0.17 B261.3%
2008 A$49.61 M85.75%
2007 A$26.71 M49.27%
2006 A$17.89 M56.98%
2005 A$11.39 M34.28%
2004 A$8.48 M